Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?

58Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

James, M. H., Fragale, J. E., Aurora, R. N., Cooperman, N. A., Langleben, D. D., & Aston-Jones, G. (2020, April 1). Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer? Neuropsychopharmacology. Springer Nature. https://doi.org/10.1038/s41386-020-0619-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free